BOSTON, MA / ACCESSWIRE / January 13, 2025 / Block & Leviton is investigating TransMedics Group, Inc. (Nasdaq:TMDX) for potential securities ...
Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback